Brief: Shield Therapeutics Announces FDA Approval Of Extension For ACCRUFeR

Shield Therapeutics

22/12/2025 07:27

Dec 22 (Reuters) - Shield Therapeutics PLC STXS.L:

SHIELD THERAPEUTICS  - FDA APPROVES EXTENSION FOR ACCRUFER®

SHIELD THERAPEUTICS PLC - FDA APPROVES ACCRUFER INDICATION EXTENSION FOR CHILDREN 10+

SHIELD THERAPEUTICS - PLANS FURTHER EXTENSION OF INDICATION FOR CHILDREN 1+ WITH NEW FORMULATION

Source text: ID:nRSV3781Ma

Further company coverage: STXS.L

 ((Reuters.Briefs@thomsonreuters.com;))